Hilltop Partners’s iShares Biotechnology ETF IBB Stock Holding History

Hilltop Partners’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$201K	Buy	+1,056	New	+$182K	0.05%	148
2025 Q3	–	Sell	-1,593	Closed	-$202K	–	122
2025 Q2	$202K	Sell	1,593 -95	-6%	-$11.7K	0.06%	113
2025 Q1	$216K	Sell	1,688 -14	-0.8%	-$1.9K	0.07%	98
2024 Q4	$225K	Sell	1,702 -10	-0.6%	-$1.41K	0.08%	94
2024 Q3	$249K	Hold	1,712	–	–	0.08%	91
2024 Q2	$235K	Hold	1,712	–	–	0.09%	88
2024 Q1	$235K	Sell	1,712 -6	-0.3%	-$819	0.08%	91
2023 Q4	$233K	Hold	1,718	–	–	0.09%	91
2023 Q3	$210K	Sell	1,718 -146	-8%	-$18.6K	0.09%	93
2023 Q2	$237K	Buy	1,864 +16	+0.9%	+$2.08K	0.1%	81
2023 Q1	$239K	Sell	1,848 -57	-3%	-$7.46K	0.11%	58
2022 Q4	$250K	Buy	+1,905	New	+$246K	0.13%	46

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Hilltop Partners's IBB Position: Q2 2026 in Review

Hilltop Partners opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 1,056 shares worth $201K. The stake represents 0.05% of the portfolio and ranks #148 among its holdings. This is a return to the name: Hilltop Partners previously reported a position in IBB as recently as Q2 2025.

Hilltop Partners first reported a position in IBB in Q4 2022 and has held it in 12 quarters since. The position peaked at $250K in Q4 2022. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Hilltop Partners held 1,056 shares of iShares Biotechnology ETF worth $201K as of Q2 2026.
iShares Biotechnology ETF was a new Hilltop Partners position in Q2 2026.
iShares Biotechnology ETF made up 0.05% of Hilltop Partners's portfolio in Q2 2026, its #148 holding.
Hilltop Partners first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 12 quarters since.
Hilltop Partners's iShares Biotechnology ETF position peaked at $250K in Q4 2022.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Hilltop Partners's 13F filing for Q2 2026, filed 5 Aug 2026.